导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -8.99% | 3684/4773 |
| 近一周 | -3.98% | 4757/5462 |
| 近一月 | -3.53% | 1814/5421 |
| 近一季 | -10.75% | 3571/5209 |
| 近半年 | -18.44% | 4264/4920 |
| 近一年 | -9.29% | 3316/4366 |
| 近两年 | 43.06% | 1735/2954 |
| 近三年 | 6.74% | 1806/2253 |
| 成立以来 | -36.08% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.10% 1062/4961 |
-4.45% 3510/5312 |
- - |
- - |
| 2025 | 18.23% 2333/4813 |
3.28% 1132/3635 |
3.16% 1132/4076 |
12.24% 3089/4524 |
-1.14% 2845/4813 |
| 2024 | 7.45% 1655/3463 |
-5.23% 1854/2808 |
-10.84% 2473/3014 |
18.40% 1012/3129 |
7.40% 451/3463 |
| 2023 | -11.67% 1418/2656 |
3.86% 1106/2280 |
-2.94% 719/2385 |
-6.18% 1449/2515 |
-6.61% 1846/2655 |
| 2022 | -24.29% 1205/2207 |
-13.47% 762/1919 |
-2.11% 1765/2016 |
-8.95% 232/2113 |
-1.85% 1746/2208 |
| 2021 | 22.56% 141/1822 |
7.22% 79/1255 |
-5.03% 1269/1330 |
15.19% 77/1466 |
4.49% 329/1822 |
| 2020 | -1.11% 949/1250 |
-3.83% 325/1028 |
3.98% 920/1067 |
6.60% 825/1164 |
-7.23% 1152/1184 |
| 2019 | 6.53% 738/1092 |
22.96% 567/754 |
-5.89% 487/804 |
-8.84% 829/850 |
0.98% 880/918 |
| 2018 | -43.71% 620/834 |
- - |
- - |
- - |
-9.23% 137/691 |
| 2017 | -7.21% 520/714 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 汇添富中证环境治理指数(LOF)A VS. 长安沪深300非周期A(740101) |